In this video Thomas Wisniewski, MD, director of NYU Langone’s Alzheimer’s Disease Research Center, discusses recent advancements in Alzheimer's disease care.

Experimental drug NU-9—a small molecule compound approved by the U.S. Food and Drug Administration (FDA) for clinical trials ...

According to the Alzheimer's Association, nearly 7 million Americans have Alzheimer's disease. Now, a new blood test is ...